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ABSTRACT
Chitosan is a natural product derived from chitin that possesses hypocholesterolemic properties. However, the mechanism of its
cholesterol-lowering effect is still unclear. This study was designed to investigate the effect of chitosan on plasma lipoprotein cholesterol, liver cholesterol and fecal excretion of cholesterol and bile acid in hamsters. Hamsters were fed a high-cholesterol (0.2%)
diet containing 4% cellulose (CE) or 4% chitosan (CS) for eight weeks. The hamsters fed the CS diet had significantly lowered
plasma total cholesterol (TC), very low-density lipoprotein cholesterol (VLDL-C) and low-density lipoprotein cholesterol (LDL-C)
than those fed the CE diet. CS had no effect on high-density lipoprotein cholesterol (HDL-C) level, but higher ratio of HDL-C to TC
was observed in hamsters fed the CS diet when compared with those fed with the CE diet. In addition, CS did not change plasma triglyceride and cholesteryl ester transfer protein (CETP) activity. Hepatic cholesterol contents were significantly lower in hamsters fed
CS primarily due to the reduced accumulation of the esterified cholesterol. Fecal excretion of cholesterol and bile acid were significantly increased in hamsters after the CS treatment. Results from this study suggest that the cholesterol-lowering effect of CS may be
primarily related to an increase in fecal excretion of cholesterol and bile acid in hamsters.
Key words: chitosan, cholesterol, lipoprotein, hamsters

INTRODUCTION
Epidemiological st udies in hu man populations
indicates that hypercholesterolemia is an important risk
factor for coronary heart disease (1), and that increased
dietary fiber intake is suggested to decrease plasma
cholesterol concentration (2,3). Chitosan, a biopolymer
of glucosamine derived from chitin that is chemically
si m i l a r t o t h a t of c el lu lo s e , i s n ot d ige s t i ble by
mammalian digestive enzymes and acts as a dietary fiber
in gastrointestinal tract (4). Animal studies have shown
that chitosan feeding may inhibit dietary fat digestion(5,6)
and decrease plasma cholesterol concentration (4,7-11) .
I nc r e a se d fe c a l chole st e rol a c c omp a n ie d w it h or
without bile acid excretion by interfering intestinal
micelle formation is believed to be responsible for its
hypocholesterolemic properties (4,7). However, the exact
mechanisms of actions are not fully clear.
Previous rat st udies have show n that chitosan
remarkably decreases plasma V LDL- C and LDL- C
while it increases HDL-C levels, which result in a less
atherogenic lipoprotein prof ile (10,11) . However, the
benef icial effect of chitosan on elevating HDL-C or
lowering LDL-C is mild or unobserved in recent clinical
trials (12-14). In addition, most of the studies related to
chitosan and weight loss have been conducted on rats
and the anti-obesity effects of chitosan may be caused by
the inhibition of intestinal absorption of dietary fat (5,6).
However, only small change or no effect on human body
weight loss and fecal fat excretion was observed due to
* Author for correspondence. Tel: +886-2-24622192 ext. 5118;
Fax: +886-2-24634203; E-mail: a0071@mail.ntou.edu.tw

chitosan supplementation (13,14) . The main reason for
these discrepancies seems to be related to the differences
in the amount of dietary chitosan ingested, chemical
composition of chitosan used and cholesterol metabolism
difference between rat and human.
The Golden-Syrian hamsters have been extensively
used for investigation of dietary cholesterol on lipoprotein
and bile acid metabolism and the mechanism involved
because they have similar responses to dietary factors,
i.e dietary fiber and cholesterol that are known to alter
plasma cholesterol levels in humans (15). Advantages of
this animal model compared with others of comparable
size include the presence of LDL receptor-mediated and
cholesteryl ester transfer protein (CETP) activities (16).
However, relatively less information is available on the
effect of chitosan on lipid metabolism in hamsters(8).
The present st udy was desig ned to investigate
the effects of chitosan on lipoprotein cholesterol and
triglyceride distribution, hepatic cholesterol levels, and
fecal excretion of cholesterol and bile acid in hamsters.
Plasma hormones such as leptin and insulin that are
directly propor tional to body fat (17,18) and provide
signals to metabolism and energy balance will also be
determined. In this study, cellulose was used as a control
fiber since it dose not affect plasma lipoprotein cholesterol
concentrations in hamsters(19).

MATERIALS AND METHODS
I. Chitosan and Cellulose
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The chitosan, prepared from shrimp shell chitin,
was generously supplied by the Taiwan Tanabe Seiyaku
Co (Taipei, Taiwan). The degree of deacetylation of
chitosan was about 90%, and the average molecular weight
was about 800 KD. The cellulose used in the study was
purchased from Sigma Chemical Co. (St Louis, MO, USA).
II. Animals and Treatment
Eig h t e e n fo u r-we e k- old m a le h a m s t e r s we r e
purchased from the Animal Center of the National Science
Council (Taipei, Taiwan). During the adaptation period,
hamsters were fed a chow diet (Rodent Laboratory Chow,
Ralston Purina, St. Louis, MO, USA) for two weeks.
Then the animals were randomly divided into two groups
with nine animals in each group; (a) the cellulose group
(CE; control group) and (b) the chitosan group (CS group),
and the average body weights were 98.1 ± 12.9 g, and 98.3
± 11.9 g, respectively, for the CE and CS groups. The
composition of the experimental diet given to test animals
is shown in Table 1. Hamsters were housed in individual
stainless cages in a room kept at 23 ± 1°C and 60 ± 5%
relative humidity with a 12-hr light and dark cycle (lighting
from 8:00 a.m. to 8:00 p.m.). Food and drinking water
were available ad libitum for eight weeks. Food intake
was measured daily, and body weight was measured
every week. Feces were collected from each animal
during the last 3 days of the experiment, freeze-dried and
weighed. This study was approved by the Animal House
Management Committee of the National Taiwan Ocean
University. The animals were maintained in accordance
with the guidelines for the care and use of laboratory

Table 1. Composition of the experimental dieta (%)
CE

CS

Casein
Ching-Shiang oilb

Ingredient

20
3

20
3

Corn oil

7

7

Vitamin mixturec

1

1

Mineral mixtured

4

4

Cholesterol

0.2

0.2

Choline chloride

0.2

0.2

L-cystein

0.3

0.3

Cellulose

4

Chitosan
Sucrose
Corn starch
Total
a

4
25

25

34.3
100

34.3
100

CE: cellulose group; CS: chitosan group.
Ching-Shiang oil: contained about 26% palmitic acid, 3% stearic
acid, 54% oleic acid and 17% linoleic acid.
c
AIN 76 vitamin mixture: procured from ICN Biochemicals (Costa
Mesa, CA).
d
AIN 76 mineral mixture: procured from ICN Biochemicals (Costa
b

animals as issued by the Animal Center of the National
Science Council.
III. Collection of Blood and Tissue Samples
At the end of the experimental period, animals were
fasted for 12 hr prior to being sacrificed. Animals were
killed by exsanguinations via the abdominal aorta while
under diethyl ether anesthesia. Heparin was used as the
anticoagulant. Plasma was separated from the blood by
centrifugation (1,750 ×g) at 4°C for 20 min. Liver and the
adipose tissues (epididymal + abdominal) from each animal
were excised, weighed, and stored at -80°C for analysis.
IV. Determination of Plasma Lipids Concentration
Plasma tot al cholesterol a nd t r iglycer ide
concentrations were determined by an enzymatic method
provided by the kits purchased from Audit Diagnostics
(Cork, Ireland). The concentrations of VLDL, LDL and
HDL in plasma were determined subsequent to plasma
ultracentrifugation (194,000 ×g for 3 hr at 10°C)(20). The
total cholesterol and triglyceride levels of the VLDL, LDL
and HDL fraction were measured by the same method
applied to the plasma.
V. Determination of Plasma Insulun, Leptin and Glucagon
Levels
The hamster plasma insulin (Mercodia, Uppsala,
Sweden), leptin (Assay Designs, Ann Arbor, MI, USA)
and glucagon (Linco Research, St. Louis, MO, USA)
concent r at ion s we re det e r m i ned a ccord i ng to t he
procedures provided by the commercially available
enzyme immunoassay kits.
VI. Determination of Plasma Cholesteryl Ester Transfer
Protein (CETP) Activity
Plasma CETP activity was determined flurometrically
according to the procedures provided by the kit purchased
from Kamiya Biomedical Company (Seattle WA, USA).
The excitation wavelength was 465 nm and the emission
wavelength was 535 nm.
VII. Determination of Hepatic Cholesterol and Triglyceride
Contents
Lipids were extracted from liver by the method of
Folch et al.(21) and solubilized in Triton X-100 according
to the method of Carlson and Goldfarb (22). The hepatic
total cholesterol and triglyceride contents were assayed
enzymatically by the same method used to measure the
concentrations of total cholesterol and triglycerdie in
plasma. Free cholesterol concentration in the liver extract
was determined according to the procedures provided by
the assay kit purchased from Pure Chemical Co., (Osaka,
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Japan). The cholesteryl ester concentrations were calculated
as the difference between total and free cholesterol.

or cellulose diet for eight weeks. However, a slight (8%)
but statistically significant reduction on relative liver
weight was observed in hamsters fed on the chitosan diet
when compared with those fed on the cellulose diet.

VIII. Determination of Fecal Cholesterol and Bile Acid
Contents

II. Plasma Lipids Concentration

Fecal lipids were extracted from dry feces by the
method of Folch et al.(21). Fecal cholesterol concentration
was assayed by the method used to determine the hepatic
total cholesterol concentration. Total fecal bile acids
were extracted by the method of Cheng and Lai(23), and
quantified enzymatically according to the procedures
prov ided i n t he assay k it pu rchased f rom R a ndox
Laboratories Ltd. (Antrim, UK).

Hamsters fed on the chitosan diet showed no change
on the concentration of plasma TG but plasma TC was
reduced by 13% compared to those fed on cellulose (Table
3). Statistically significant decreases in plasma VLDL-C
(-38.9%) and LDL-C (-12.7%) that resulted in a significant
increase in plasma ratio of HDL-C to TC were observed
in the animals fed with chitosan (Table 4). No significant
change in lipotrotein triglyceride levels was observed
between the two dietary groups. In addition, a lower ratio
of VLDL-C to VLDL-TG was observed after the chitosan
treatment.

IX. Statistical Evaluation
Data were presented as the mean ± standard deviation
(SD). Statistical analyses were preformed using Student’s
t-test. The difference was considered significant when p <
0.05.

III. Plasma Concentrations of Insulin, Leptin, Glucagon
and CETP Activity
No significant difference in plasma concentrations of
insulin, leptin, glucagon and CETP activity was observed
between the two dietary groups (Table 3).

RESULTS
I. Body Weight and Tissue Weight

IV. Hepatic Cholesterol and Triglyceride Levels

As shown in Table 2, there was no difference on
body weight and adipose tissue (epididymal + abdominal)
weight between the two groups of animals fed on chitosan

Table 5 shows the contents (mg / liver) and the
concentrations (mg/g of liver) of total and free cholesterol,

Table 2. Food intake, final body weight, liver weight and adipose tissue weight of hamsters fed on the chitosan and cellulose diets for 8
weeksa
Diet
Cellulose
Chitosan

Body weight

Food intake

(g)

(g/day)

(g)

Liver weight
(g/100g body weight)

(g)

Adipose tissue weight
(g/100g body weight)

122.5 ± 13.4
122.2 ± 13.0

7.9 ± 0.4
7.8 ± 0.6

6.2 ± 1.1
5.6 ± 0.6

5.0 ± 0.3
4.6 ± 0.3*

2.5 ± 0.7
2.7 ± 0.8

2.0 ± 0.3
2.2 ± 0.5

a

Values are expressed as mean ± SD for 9 hamsters per dietary group. *Significant difference from the control group at p < 0.05.

Table 3. Plasma total cholesterol, triglyceride, insulin, glucagon, leptin and cholesteryl ester transfer protein (CETP) activity in hamsters fed
on the chitosan and cellulose diets for 8 weeksb

b

Diet

Total cholesterol
(mg/dL)

Triglyceride
(mg/dL)

CETP
(nmol/mL/hr)

Insulin
(pg/mL)

Leptin
(pmol/mL)

Glucagon
(pg/mL)

Cellulose
Chitosan

237.6 ± 10.7
207.3 ± 22.7*

97.3 ± 38.3
78.5 ± 26.2

2.86 ± 0.23
2.71 ± 0.15

1794.6 ± 655.8
1387.4 ± 437.6

111.4 ± 22.8
122.8 ± 21.2

279.1 ± 83.6
265.2 ± 27.8

Values are expressed as mean ± SD for 9 hamsters per dietary group. *Significant difference from the control group at p < 0.05.

Table 4. Plasma lipoprotein cholesterol and triglyceride levels in hamsters fed on the chitosan and cellulose diets for 8 weeksa
Cholesterol (mg/dL)

Diet
Cellulose
Chitosan
a

Cholesterol (mg/dL)

VLDL

LDL

HDL

VLDL

LDL

HDL

HDL-C/TC

VLDL-TC/VLDL-TG

47.5 ± 10.5
29.0 ± 10.0*

69.5 ± 5.9
60.7 ± 7.6*

120.1 ± 9.9
118.0 ± 13.6

38.2 ± 8.9
36.2 ± 7.5

27.6 ± 14.9
15.6 ± 12.5

28.6 ± 7.6
26.9 ± 3.3

0.51 ± 0.03
0.57 ± 0.03*

1.24 ± 0.16
0.80 ± 0.31*

Values are expressed as mean ± SD for 9 hamsters per dietary group. *Significant difference from the control group at p < 0.05.
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Table 5. Liver lipids content in hamsters fed on the chitosan and cellulose diets for 8 weeksa
Diet
Cellulose
Chitosan

Total cholesterol

Free cholesterol

Cholesteryl ester

Triglyceride

(mg/g)

(mg/liver)

(mg/g)

(mg/liver)

(mg/g)

(mg/liver)

(mg/g)

(mg/liver)

98.2 ± 6.5
57.1 ± 11.0*

608.2 ± 106.1
332.3 ± 66.9*

19.9 ± 2.9
18.9 ± 2.3

122.7 ± 20.7
103.8 ± 15.0

78.3 ± 6.4
38.2 ± 9.2*

485.5 ± 93.6
235.3 ± 60.6*

12.8 ± 8.6
9.6 ± 1.8

74.9 ± 39.0
56.3 ± 11.5

a

Values are expressed as mean ± SD for 9 hamsters per dietary group. *Significant difference from the control group at p < 0.05.

V. Fecal Excretion of Cholesterol and Bile Acid
Hamsters consuming the chitosan diet had higher
fecal cholesterol concentration, as compared to hamsters
fed the cellulose diet, at the end of experimental period
(2.9 ± 1.0 mg/g for cellulose group; 9.6 ± 2.3 mg/g for
chitosan group). In addition, chitosan induced an increase
in fecal bile acid concentration in hamsters. The fecal bile
acid concentration for the hamsters fed on chitosan diet
(4.0 ± 1.6 μmol/g) was significantly higher than that of the
animals that received the cellulose diet (1.4 ± 0.7 μmol/g).
The average daily fecal excretion of cholesterol and bile
acid was significantly enhanced in hamsters fed on the
chitosan diet compared to those fed on the cellulose diet
(Figures 1 and 2).

14

10

8

6

4

2

0

Cellulose

Chitosan

Figure 1. Daily fecal excretion of cholesterol in hamsters fed on
a diet containing cellulose or chitosan for 8 weeks. Values are
expressed as mean ± SD for 9 hamsters. *Significant difference
from the control group at p < 0.05.

DISCUSSION

6

*
5

Fecal bile acid (μmol/day)

The present study confirms the consistently reported
cholesterol-lowering effect of chitosan. In this study,
chitosan lowered plasma total cholesterol, VLDL-C
and LDL-C concentration in hamsters compared to
the cellulose-treated control group. This f inding is
in agreement with the results of our previous studies
in rats (10,11), although with less degree of cholesterollowering effect. In addition to the plasma cholesterollowering effect, the present st udy also showed that
chitosan sig nif icantly en hanced fecal excretion of
cholesterol and bile acid and reduced hepatic cholesteryl
ester.
Hamsters (24) or rats (25) fed with high cholesterol
diet may enhance hepatic cholesterol accumulation that
result in increased esterification and storage. Hepatic
cholesterol accu mulation caused by high intake of
dietary cholesterol may down-regulate the activity of
3-hydroxyl-3-methylglutaryl-coenzyme A (HMG-CoA)
reductase (26) and the mRNA levels for apoB/E receptor
that are associated with decreases in LDL uptake (27). This
study showed that daily fecal excretion of cholesterol was
significantly increased by chitosan resulting in a decrease
in hepatic cholesterol level primarily in the form of

*

12

Fecal cholesterol (mg/day)

cholesteryl ester and triglyceride in the liver of hamsters
treated with chitosan or cellulose, respectively. Chitosan
significantly decreased the concentrations as well as the
contents of hepatic total cholesterol and cholesteryl ester
but had no effect on free cholesterol and triglyceride when
compared with cellulose.

4

3

2

1

0

Cellulose

Chitosan

Figure 2. Daily fecal excretion of bile acid in hamsters fed on a diet
containing cellulose or chitosan for 8 weeks. Values are expressed
as mean ± SD for 9 hamsters. *Significant difference from the
control group at p < 0.05.
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cholesteryl ester. These data were consistent with previous
findings in rat that chitosan reduced intestinal absorption
of cholesterol (4,28) and reduced hepatic cholester yl
ester accumulation in rats (10,11). In addition, fecal bile
acid excretion, the major degradation of endogenous
cholesterol, was enhanced after chitosan feeding to
hamsters might stimulate the synthesis of bile acid using
cholesterol as the precursor. It has been proposed that
in hamsters, cholesterol used for bile acid synthesis is
preferentially derived from plasma rather than newly
synthesized cholesterol(29). Although we did not measure
hepatic HMG-CoA reductase activity of hamsters in this
experiment, LeHoux and Grondin(30) demonstrated lack of
significant difference on the hepatic HMG-CoA reductase
activity in rats fed a diet enriched in cholesterol and
chitosan. Taken together, these results suggested that the
hypocholesterolemic effect of chitosan in hamsters may be
related to lower absorption of cholesterol and bile acids,
resulting in a decrease in hepatic cholesterol accumulation
and in an increase in hepatic cholesterol catabolism, and
thus leading to an increase in hepatic uptake of plasma
cholesterol via the LDL receptor.
Previous studies have reported that the in vitro bile
acid binding capacity and plasma and liver cholesterollowe r i ng ef fe c t of ch it o s a n we r e of a m a g n it ude
approximately equivalent to that of cholestyramine (31).
Chitosan is dissolved in the aqueous acidic f luid of
stomach and the amino groups (-NH 2) of chitosan take on
hydrogen ions (H+) to become positively charged tertiary
amino group (-NH 3 +), as well as leads to an unique
intrinsic property of chitosan in term of binding with
negatively charged molecules, i.e fatty and bile acids (32).
However, as chitosan enters into the intestine with weak
alkaline environment, its hydrogen ions (H +) may be
lost and subsequently diminish its bile acid binding
capacity. This might be one of the reasons to explain
why chitosan did not increase fecal bile acid excretion in
several studies(31,33). It is possible that the physiochemical
proper t ies of ch itosa n, such a s molecu la r weig ht,
deacetylation and viscosity, may also determine its effect
on fecal cholesterol and bile acid excretion. Therefore, the
mechanism action of cholesterol-lowering effects between
chitosan and cholestyramine appears to be different.
Although the hypolipidemic properties of chitosan are
well known, fewer investigators have focus on its effect
on lipoprotein metabolism. Many studies have clearly
demonstrated that chitosan reduces plasma cholesterol
without lowering plasma triglyceride (11,13,14,34,35). In
this study, hamsters fed chitosan significantly decreased
plasma VLDL-C without lowering VLDL-TG, and resulted
in lower ratio of cholesterol/triglyceride in VLDL fraction,
suggesting that the livers from these animals secreted
VLDL that reflected their hepatic lipid composition and
hepatic VLDL lipid composition may be modified by
chitosan. These findings are in line with our previous
rat studies; the hypocholesterolemic effect of chitosan
was due mainly to a decrease in cholesterol carried

in VLDL fraction (10,11) . On the other hand, chitosan
feeding in rats have shown to stimulate hepatic fatty acid
synthetase activity, which is possibly resulted from the
decreased absorption of dietary fat (11). The increment
of de novel fatty acid synthesis may provide substrate
for further hepatic TG synthesis and VLDL assembly.
In this study, no significant difference in hepatic TG
and VLDL-TG was observed between hamsters fed on
cellulose diet and chitosan diet. Therefore, it appears
that hepatic VLDL secretion is not impaired in hamsters
after chitosan treatment. In addition, it is expected that
VLDL with a low cholesterol/triglyceride ratio will be
efficiently hydrolysed by lipoprotein lipase (LPL), thus
leading to formation of a smaller particle with atherogenic
potential(36). However, lower LDL-C concentration was
found in hamsters fed on chitosan diet than in those fed on
cellulose diet despite a decrease in cholesterol/triglyceride
ratio in VLDL caused by chitosan. Plasma cholesterol
lowering effect of chitosan in hamsters may be possibly
associated with faster VLDL fractional catabolic rates and
removed from the circulation by hepatic receptors, since
reduced hepatic cholesterol accumulation and enhanced
fecal bile acid excretion by chitosan may up regulate
hepatic LDL receptor.
Cholesterol ester t ransfer protein (CETP), is a
protein that transfers cholesterol ester from HDL to
VLDL and LDL(37), is thought to participate in a pathway
of reverse cholesterol transport in which cholesterol,
esterified within HDL by the action of lecithin: cholesterol
acyltransferase, is transported from peripheral tissue to
the liver (38,39). Some investigators have indicated that
chitosan had lowered plasma TC and elevated HDL-C
concent r at ion (10,11, 34,4 0) . T here wa s, however, no
signif icant difference in CETP activity between the
chitosan group and the cellulose group, whereas animals
fed on chitosan had lower plasma TC concentration and
higher HDL-C/TC ratio. Thus, the hypocholesterolemic
effect of chitosan may not be directly related to its effect
on CETP activity.
On the other hand, some previous rat studies showed
that chitosan feeding over 7% reduced food intake and
increased fecal fat excretion, resulted in reduced average
daily energy intake and reduced body weight gain (4,11).
Similar results are found in hamsters, though these effects
are diminished when chitosan supplemetation is reduced
from 8% to 4%(8). In this study, however, no significant
difference existed in food intake, body weight and adipose
tissue weight in hamsters between the two dietary groups.
We also found that 4% chitosan feeding in hamsters had
no significant effect on plasma hormones, such as leptin,
insulin and glucagon levels that are known as a regulator
on food intake and energy homeostasis(41,42), suggesting
that the energy balance is not altered after long-term
feeding of chitosan. Therefore, the long-term chitosan
supplementation appears to be useful to induce or to
maintain weight loss under unrestricted condition. Since
these hormones cannot only inf luence on body weight
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and energy balance but also provide important signals
to regulate lipid metabolism as well(43,44) our study first
demonstrated that the hypocholesterolemic effect of
chitosan also may not be directly related to its effect on
hormone regulations.
In conclusion, the findings of this study emphasize
the cholesterol-lowering potential of chitosan in hamsters.
Chitosan feeding in hamsters may significantly reduce
hepatic cholesteryl ester accumulation and lower plasma
VLDL cholesterol, which is similar to rats although its
plasma cholesterol-lowering effect is lessened. Our study
further suggests that these effects of chitosan may be
mediated by enhancing fecal excretion of cholesterol and
bile acid.
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